The story of copyright's flagship drug presents a complex case for observers in the drug sector. While initially a blockbuster success, generating vast sums, the patent expiration and the subsequent entry of cheaper https://pharma669083.blogacep.com/47419549/the-little-copyright-and-the-pharmaceutical-industry-a-risky-investment